Diamines & Chemicals Ltd. (DIAMINESQ) AI Stock Analysis

• Market Cap: ₹2.24B
• Dividend Yield: 0.38%
• Average Volume (3M): 948.00
• Price to Earnings (P/E): ―
• Beta (1Y): 1.00
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: IN
• Employees: 151
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals
• EPS (TTM): -3.48
• Shares Outstanding: 9,783,990
• 10 Day Avg. Volume: 829
• 30 Day Avg. Volume: 948
• PEG Ratio: -1.45
• Price to Book (P/B): 2.03
• Price to Sales (P/S): 4.58
• P/FCF Ratio: -36.22
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 43 Neutral
• Price Target: ₹221.00 ▼(-15.83% Downside)
• Action: N/A Date: 01/04/26
• Date: Action: N/A 01/04/26

The score is primarily held back by weak FY2025 financial performance—sharp margin compression and negative operating/free cash flow—despite a very conservative, low-debt balance sheet. Technicals also remain bearish (below key moving averages with negative MACD), and valuation support is limited given a negative P/E and a very low dividend yield.

Positive Factors

Conservative balance sheet

The company’s near-zero leverage and conservative balance sheet materially reduce refinancing and solvency risk over a multi-month horizon. That structural financial strength preserves optionality for capex, working-capital support, or opportunistic investments during downcycles.

Proven margin potential

Historic multi-year periods of strong gross and operating margins indicate the business can achieve attractive profitability when volumes or pricing normalize. This demonstrates structural upside potential from product mix, pricing power, or operational leverage over the medium term.

Growing equity base

A steadily expanding equity base provides a durable capital buffer that reduces insolvency risk and supports investment without relying on debt. This improves resilience to cyclical shocks and complements the low-leverage profile for longer-term financial flexibility.

Negative Factors

Revenue decline & margin compression

A sharp fall in revenue combined with a large drop in EBIT margin signals structural demand weakness or rising operating cost pressures. Sustained margin erosion undermines cash generation and return profiles, making recovery reliant on meaningful operational improvements or stronger end-market demand.

Negative operating and free cash flow

Negative OCF and FCF indicate cash-conversion and working-capital stress, reducing the company’s ability to self-fund operations, capex, or dividends. Even with low debt, sustained cash outflows increase reliance on external funding or equity and constrain strategic flexibility.

Weak returns & earnings volatility

A collapse in ROE and extreme negative EPS growth highlight earnings volatility and poor capital returns. Persistently low returns erode long-term shareholder value, limit reinvestment yields, and raise execution risk for management to restore sustainable profitability.

Diamines & Chemicals Ltd. Business Overview & Revenue Model

Company Description

Diamines and Chemicals Limited manufactures and sells organic chemical compounds in India. The company's products include piperazine anhydrous, ethylenediamine, diethylenetriamine, aminoethylpiperazine, triethylenetetramine, tetraethylenepentamine, polyethylene polyamine-mix, monoethanol amine, triethylenediamine, diaminopropane, dipropylene triamine, diacetyl ethylenediamine, tetracetyl ethylenediamine, tetra methyl ethylenediamine, and amine mixture, as well as piperazine derivatives. It exports its chemical products. The company was incorporated in 1976 and is based in Vadodara, India.

How the Company Makes Money

null

Diamines & Chemicals Ltd. Financial Statement Overview

Summary

FY2025 showed a sharp deterioration in operating results and cash conversion: revenue fell (-12.5%), EBIT margin dropped materially (~7.2% vs ~21.7% in FY2024), and both operating cash flow (-50.2m) and free cash flow (-90.4m) turned negative. The balance sheet remains a key strength with near-zero leverage, but returns weakened (ROE ~1.7%), keeping the overall financial profile below average.

Income Statement

Profitability weakened sharply in FY2025: revenue declined (-12.5%) and net margin compressed to ~3.8% (vs ~15.0% in FY2024). While gross margin improved (~49.5% vs ~43.2% last year), operating profitability deteriorated materially (EBIT margin down to ~7.2% vs ~21.7% in FY2024), pointing to higher operating costs and/or weaker operating leverage. Multi-year results show the business can generate strong margins in better cycles (notably FY2020–FY2022), but earnings have been volatile and the recent step-down is a key concern.

Balance Sheet

Balance sheet is very conservatively positioned with near-zero leverage (debt-to-equity ~0.0002 in FY2025) and a steadily growing equity base over time. This low debt load reduces financial risk and gives flexibility through downcycles. The main weakness is the drop in returns: return on equity fell to ~1.7% in FY2025 (from ~10.4% in FY2024), reflecting the sharp decline in profitability rather than balance sheet stress.

Cash Flow

Cash generation weakened significantly in FY2025, with operating cash flow turning negative (-50.2m) and free cash flow also negative (-90.4m), despite positive net income—suggesting working-capital outflows and/or cash conversion pressure. Prior years were generally stronger (positive operating cash flow and free cash flow in FY2024, FY2022, FY2021, FY2020), but the latest year introduces higher cash-flow volatility risk and reduces near-term financial flexibility.

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	569.97M	714.72M	1.03B	1.10B	658.90M	626.92M
Gross Profit	259.06M	353.88M	444.26M	737.89M	375.84M	400.07M
EBITDA	-4.46M	86.12M	251.30M	581.54M	237.95M	275.95M
Net Income	-49.48M	27.31M	154.71M	419.04M	167.14M	209.95M
Balance Sheet
Total Assets	1.77B	1.78B	1.63B	1.51B	1.11B	947.79M
Cash, Cash Equivalents and Short-Term Investments	348.36M	413.96M	362.95M	248.05M	390.90M	311.12M
Total Debt	98.15M	251.00K	0.00	0.00	0.00	3.02M
Total Liabilities	232.88M	168.31M	145.62M	165.51M	103.56M	97.92M
Stockholders Equity	1.54B	1.61B	1.48B	1.35B	1.00B	849.87M
Cash Flow
Free Cash Flow	-199.95M	-90.37M	132.88M	-70.06M	123.03M	40.55M
Operating Cash Flow	-71.15M	-50.22M	218.96M	162.85M	272.74M	153.66M
Investing Cash Flow	-108.41M	146.54M	-188.33M	-86.63M	-214.91M	-149.27M
Financing Cash Flow	87.33M	97.47M	-31.29M	-60.15M	-52.80M	-36.86M

Diamines & Chemicals Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
INDOAMIN	63 Neutral	₹6.65B	19.71	―	0.38%	13.01%	32.44%
INDOBORAX	63 Neutral	₹7.80B	24.50	―	0.38%	12.35%	6.79%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
DMCC	61 Neutral	₹5.62B	25.70	―	0.97%	40.79%	109.95%
LORDSCHLO	54 Neutral	₹3.00B	23.33	―	―	39.31%	―
KANORICHEM	45 Neutral	₹2.71B	23.83	―	―	-1.30%	-27.85%
DIAMINESQ	43 Neutral	₹2.24B	-19.09	―	0.38%	―	―